Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

You are viewing the site in preview mode

Skip to main content
Fig. 4 | Virology Journal

Fig. 4

From: Inhibitory effect of Alantolactone against varicella-zoster virus in vitro

Fig. 4

ALT inhibited VZV-induced IL6 expression in WI-38 cells. (A) Venn graph. Differentially expressed genes (DEGs) and overlapped DEGs in Mock, DMSO + VZV and ALT + VZV group. (B) Pathways linked to inflammation were revealed via KEGG enrichment analysis of overlapped genes. (C) PPI networks identified IL-6 as a hub gene. (D) The inhibitory effect of ALT on IL-6 transcriptional level in VZV-infected WI-38 cells. WI-38 cells were infected with VZV at MOI of 0.04 and treated with or without ALT (10µM). Total RNA was isolated at 3dpi and subjected to qPCR analysis (n = 3). (E) WI-38 cells were inoculated with VZV at MOI of 0.04 and treated with either DMSO or ALT at 10µM. At 0, 2 or 3 days after infection, samples were harvested to analyze the protein levels of IL-6 using Western blotting. The experiment had been repeated three times and one of the typical results was presented. P values were calculated with one-way ANOVA. ( ****P < 0.0001, ns means no significance)

Back to article page